Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic

James C Weaver1,2, Inaam Ullah1,3, Miao Qi1,4

  • 1University of NSW, Sydney, Australia (J.C.W., I.U., M.Q., B.G., K.A.R., S.A.K.).

Abstract

Insights

Higher levels of free thiol beta-2-glycoprotein I (β2-GPI) predict the presence and severity of stable coronary artery disease. This redox form was a stronger predictor than high-sensitivity C-reactive protein.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Atherosclerotic coronary artery disease is an inflammatory condition influenced by oxidative stress.
  • Beta-2-glycoprotein I (β2-GPI) is a plasma protein with distinct free thiol and oxidized redox forms.
  • The role of β2-GPI redox states in coronary artery disease pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the association between the post-translational redox forms of β2-GPI and atherosclerotic coronary artery disease.
  • To determine if free thiol β2-GPI predicts the presence and extent of coronary artery disease in stable patients.
  • To compare the predictive value of free thiol β2-GPI against hs-CRP in stable coronary artery disease.

Main Methods:

  • Prospective recruitment of stable patients undergoing coronary angiography and acute coronary syndrome patients post-myocardial infarction.
  • Quantification of total and free thiol β2-GPI levels in serum and plasma.
  • Assessment of coronary artery disease extent using Syntax and Gensini scores.

Main Results:

  • Total β2-GPI levels did not correlate with stable coronary artery disease.
  • Elevated free thiol β2-GPI levels were significantly associated with the presence and extent of stable coronary artery disease.
  • Free thiol β2-GPI demonstrated superior predictive capability for stable coronary artery disease compared to hs-CRP.
  • Conversely, lower free thiol β2-GPI levels were observed in patients with ST-segment-elevation myocardial infarction.

Conclusions:

  • Free thiol β2-GPI serves as a significant predictor of coronary artery disease presence and severity in stable patients.
  • The predictive power of free thiol β2-GPI surpasses that of hs-CRP for stable coronary artery disease.
  • The paradoxical finding of lower free thiol β2-GPI in acute myocardial infarction warrants further investigation.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
247
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
720
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
557
Inflammation01:38

Inflammation

Overview
60.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
298